BioSpace News Archive

Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, and Strategic Science & Technologies, LLC (SST), a Cambridge, MA based novel topical drug delivery company, today announced the initiation of the Phase 2b RESPOND clinical study of Sildenafil Cream, 3.6% for the treatment of female sexual arousal disorder (FSAD).

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announces the publication of a scientific paper in the peer-reviewed international medical journal, CNS Drugs

Scipher Medicine®, a precision immunology company matching patients with the most effective therapy, announced the completion of its Series C financing led by aMoon and Northpond Ventures, with participation from Echo Health Ventures and existing investors, Khosla Ventures and Alumni Ventures

Tivic Health® Systems Inc., a first-in-class developer of bioelectronics health devices, today announced that the U.S. Food and Drug Administration (FDA) has expanded the indication for use of ClearUP® Sinus Pain Relief to include congestion from allergies, the flu, and the common cold.

DeciBio Analytics, the market intelligence subsidiary of DeciBio Consulting, has launched the 2021 edition of the DxBooks. These clinical diagnostic databases include the Infectious Disease DxBook, the Oncology DxBook, and the SARS-CoV-2 DxBook. Formerly known as the Emmes Databases,

Bioniz Therapeutics, Inc., (“Bioniz”), a clinical-stage biopharmaceutical company advancing a pipeline of first-in-class peptide-based multi-cytokine inhibitors for the treatment of cancer and autoimmune diseases, announced today the appointment of Alexandre Kaoukhov, M.D., as Senior Vice President and Head of Clinical Development

Akebia Therapeutics, Inc. (Nasdaq: AKBA), today announced that its collaboration partner, Japan Tobacco Inc. (JT), received approval from the Pharmaceuticals and Medical Devices Agency (PMDA) for an additional indication for Riona® Tablets 250mg (Riona) (generic name in Japan: ferric citrate hydrate) to treat adult patients with iron deficiency anemia (IDA) in Japan.

Liver cancer is the fastest growing and second deadliest cancer worldwide In China alone, more than 400,000 liver cancer diagnoses per year and nearly 100 million people living with hepatitis B virus

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the launch of the Thermo Scientific AerosolSense Sampler, a new surveillance solution designed to deliver fast and highly reliable insight into the presence of in-air pathogens, including SARS-CoV-2.

Sincerus Pharmaceuticals, the parent company of Prescriber’s Choice and Sincerus Florida, today announced the completion of a major new round of growth financing with SWK Holdings Corporation (Nasdaq: SWKH), representing what is by far the largest investment into the company to date.